Lilly, Novartis, Rackspace, Time Warner, Microsoft: Intellectual Property - Bloomberg

Eli Lilly & Co. (LLY), whose best-selling schizophrenia drug Zyprexa survived a U.K. court challenge by generic makers two years ago, lost a bid to dismiss another lawsuit over the medicine’s patent in Britain. Judge Christopher Floyd in the High Court in London yesterday denied Lilly’s request for a judgment without trial against Neopharma Ltd., the closely held company that has...